No profile data available.
Biodexa Pharmaceuticals Plc (BDRX) is a healthcare company in the digestive system treatment drugs industry, based in Cardiff, United Kingdom, with about 11 full-time employees.
It reported revenue of 0 GBP for fiscal year 2025, and net income of -6.38 million GBP. Its market capitalization was $1.01 million as of October 9, 2026.
Figures from company filings and market data; latest fiscal year ended December 31, 2025; market data as of October 9, 2026.
Biodexa Pharmaceuticals Plc, a clinical stage biopharmaceutical company, focuses on developing a pipeline of products for the treatment of familial adenomatous polyposis, non-muscle invasive bladder cancer, and Type 1 diabetes and rare/orphan brain cancer.
Biodexa Pharmaceuticals reported 0 GBP in revenue for fiscal year 2025.
$1.01 million as of October 9, 2026.
Listed companies of a similar size in the same industry (digestive system treatment drugs) include Evoke Pharma, Inc. (EVOK), Jaguar Health, Inc. (JAGX), Curanex Pharmaceuticals Inc (CURX), Itonis, Inc. (ITNS).